Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Saudi Chemical Holding Company (2230.SR)
Riyadh, Riyadh Province, SA
Saudi Chemical Holding Company is a diversified enterprise with operations in explosives, pharmaceuticals, and the production of ammonium nitrate, serving markets within Saudi Arabia and globally. The company manufactures and sells explosive materials and their derivatives for both civil and military purposes, complemented by specialized technical support services for explosive operations. Furthermore, it is deeply involved in the medical sector, encompassing the manufacturing, wholesale distribution, and retail of a broad array of products. This includes medicines, medical materials, syrups, pharmaceutical preparations, medical and surgical instruments, supplies for hospitals and healthcare centers, associated spare parts, and food items. Another core industrial activity is the production of ammonium nitrate. Established in 1972, Saudi Chemical Holding Company's headquarters are located in Riyadh, Saudi Arabia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.84% | +18.18% | +21.76% | +31.83% | +12.22% | +140.74% | +125.94% | +155.29% | +361.75% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Conglomerates: +6.1%+7.9% ★ Q1'26: +5.1% (vs Q1'25)
-
EPS growth Conglomerates: +16.9%+14.3% Q1'26: +2.5% (vs Q1'25)
-
FCF margin FCF growth · Conglomerates: +35.9%+5.0% Q1'26: +6.5% (vs Q1'25)
-
EBIT margin Conglomerates: +9.0%+6.9% Q1'26: +6.7% (vs Q1'25)
-
ROIC Conglomerates: +4.7%+12.0% ★ Q1'26: +12.0% (vs Q1'25)
-
Share dilution Conglomerates: +0.0%-0.6% ★ Q1'26: +3.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×2.18× Q1'26: 2.21× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-10 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-03 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-26 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-19 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI Saudi Arabia ETF KSA | 0.31% | 1.99M | 0.75% |
| 2 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.06% | 68.3K | 0.42% |
| 3 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.05% | 206.6K | 0.72% |
| 4 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.05% | 181.5K | 0.74% |
| 5 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.04% | 252.4K | 0.55% |
| 6 | Avantis Emerging Markets ex-China Equity ETF AVXC | 0.04% | 150.1K | 0.33% |
| 7 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.03% | 2.36M | 0.39% |
| 8 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.03% | 64.3K | 0.35% |
| 9 | Avantis Emerging Markets Equity ETF AVEM | 0.02% | 6.47M | 0.33% |
| 10 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.02% | 3.36M | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Abdullah Abdulaziz Al Zenaidi | Chief Executive Officer of Explosive Sector | — | — |
| Abdulrahman Mohammad Al-Moseed | Technical Training Director | — | male |
| Abdulsalam Musfer Al Ghamdi | Chief Executive Officer | — | — |
| Ahmed Al-Juhaimi | Head of Human Resources and Administration Department | — | — |
| Ismail Mohammed Ismail Shehadeh | Chief Executive Officer of Pharmaceutical Sector | — | — |
| Khaled Mohammed Saad Al-Bawardi | Secretary of the Board of Directors & Chief Holding Affairs Officer | — | — |
| Mohammed Mustafa Dimyati | Chief Executive Officer for Shared Services & Chief Support Services Officer | — | — |
| Salah Bateh Al-Anazi | Sales & Customer Service Director | — | male |
| Sameh Fathi Ahmed Hassan | Group Chief Financial Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2230.SR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
